Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CASTOR family member 3, pseudogene (CASTOR3P) is a human gene classified as a pseudogene, meaning it is a nonfunctional copy or incomplete homolog of a functional gene[1][6]. Predictions suggest that the putative transcript or protein product may play a role in cellular response to L-arginine and the negative regulation of TORC1 (Target of Rapamycin Complex 1) signaling pathways, and its activity is presumed to occur in the cytosol[1][5][7]. Association of the pseudogene with disease is limited, although it has been mentioned in the context of epilepsy; however, its precise role in disease or as a functional protein remains unproven, and it is generally not considered a therapeutic or druggable target[1][3][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CASTOR family member 3, pseudogene (CASTOR3P).